Reference is made to the stock exchange announcement by Lifecare ASA (the "Company") on 12 November 2025 regarding the resolution by the Extraordinary General Meeting held on the same date to reduce the par value of the Company's shares to NOK 0.10, in order to facilitate the subscription of shares and exercise of warrants in connection with the contemplated partially underwritten rights issue announced by the Company on 22 October 2025.

The share capital reduction has now been registered with the Norwegian Register of Business Enterprises. The Company's new share capital is NOK 1,906,097.30 divided into 19,060,973 shares, each with a par value of NOK 0.10.

About us
Lifecare ASA is a medical sensor company developing technology for sensing and monitoring of various body analytes. Lifecare's focus is to bring the next generation of Continuous Glucose Monitoring systems to market. Lifecare enables osmotic pressure as sensing principle. Lifecare's sensor technology is suitable for identifying and monitoring the occurrence of a wide range of analytes and molecules in the human body and in pets.

Contacts
For further information, please contact:

Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40

Renete Kaarvik, CFO, renete.kaarvik@lifecare.no, +47 94 83 82 42

This information is subject to disclosure under the Norwegian Securities Trading Act, §5-12. The information was submitted for publication, through the agency of the contact persons set out above, at 2025-12-31 10:40 CET.

Attachments
Lifecare ASA: New share capital registered

Läs mer på MFN